Who are Vivus's investors?

Vivus's investors include Aisling Capital, Frazier Life Sciences.

Vivus

2 known investors

VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.

Biotech Healthtech Medical Devices

Founders & leadership

John AmosinChief Executive Officer

Santosh T. VargheseinPresident VIVUS Global Pharmaceutical Development & Chief Medical Officer

Investors · 2

Aisling CapitalNew York

Frazier Life SciencesPalo Alto

In the news

Vivus Restructures Debt And Gains Access To New Capital | Reutersreuters.com · May 2018

Vivus Inc says has files lawsuit -- 8-K | Reutersreuters.com · Jul 2016

FDA raises safety concerns for Vivus diet pill | The Seattle Timesseattletimes.com · Feb 2012

Frequently asked questions

What does Vivus do?: VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
Who are Vivus's investors?: Vivus's investors include Aisling Capital, Frazier Life Sciences.